Jaguar Health (JAGX) Tax Provisions (2017 - 2019)

Jaguar Health (JAGX) posted quarterly Tax Provisions of $10000.0 for Q3 2019, up 101.01% quarter-over-quarter from -$990549.0 in Q4 2017.

Jaguar Health (JAGX) Tax Provisions (2017 - 2019) Analysis & Trends

Jaguar Health (JAGX) has reported Tax Provisions for 2 consecutive years, with $10000.0 the latest figure, recorded in Q3 2019.

In Q3 2019, Tax Provisions changed N/A year-over-year to $10000.0; the TTM figure through Jun 2023 stood at $10000.0 (changed N/A YoY), while the FY2019 annual figure was $10000.0, changed N/A from the prior year.
Tax Provisions climbed to $10000.0 in Q3 2019 per JAGX's latest filing, from -$990549.0 in the prior quarter.
Across five years, Tax Provisions topped out at $10000.0 in Q3 2019 and bottomed at -$12.2 million in Q3 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	292.00 Mn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	230.90 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	59.00 Mn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	15.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	75.45 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	13.31 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-90.33 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	1.90 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Jaguar Health	447,549.24	-9.62 Mn	19.11 Mn	-

Download Data